Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.
Cesaro E, Falanga AP, Catapano R, Greco F, Romano S, Borbone N, Pastore A, Marzano M, Chiurazzi F, D'Errico S, Piccialli G, Oliviero G, Costanzo P, Grosso M.
Cesaro E, et al.
PLoS One. 2022 Mar 31;17(3):e0266090. doi: 10.1371/journal.pone.0266090. eCollection 2022.
PLoS One. 2022.
PMID: 35358273
Free PMC article.